Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Use of DOACs in patients with ICH and AF resulted in a remarkable reduction in ischemic stroke, but that benefit was partially offset by an increase in ICH recurrence.

AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, announced today two poster presentations ...

For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...

Supreme Court Associate Justice Amy Lazaro-Javier has revealed that the Philippine Health Insurance Corp. is actually ...

STARTING January 2025, hemodialysis patients in Central Visayas can benefit from increased procedure coverage under the ...

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME) – ...

IV thrombolysis given within 4.5 hours of acute pontine infarction may significantly reduce neurological deterioration vs ...

aRespiratory Medicine, Imperial College School of Medicine, National Heart and Lung Institute, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK, bCancer and Blood Programme, The Hospital for ...